We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+29.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.47B
AUM Growth
+$451M
(+5%)
Cap. Flow
+$1.13B
Cap. Flow
% of AUM
11.96%
Top 10 Holdings %
Top 10 Hldgs %
21.59%
Holding
903
New
107
Increased
255
Reduced
393
Closed
103
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BPMC
Blueprint Medicines
BPMC
|
+$51.9M |
| 2 |
Merck
MRK
|
+$50.9M |
| 3 |
Danaher
DHR
|
+$45.3M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$37.8M |
| 5 |
JD.com
JD
|
+$37.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$103M |
| 2 |
Alibaba
BABA
|
+$98.6M |
| 3 |
Salesforce
CRM
|
+$62.5M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$59.4M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$48.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.61% |
| 2 | Technology | 20.94% |
| 3 | Consumer Discretionary | 8.9% |
| 4 | Financials | 8.59% |
| 5 | Communication Services | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
APA Corp
APA
$12.3B
| – | – |
-34,549
| Closed | -$864K |
|
777
Aramark
ARMK
$15.2B
| – | – |
-92,580
| Closed | -$2.84M |
|
778
Axalta
AXTA
$7.22B
| – | – |
-7,227
| Closed | -$215K |
|
779
Banco Bilbao Vizcaya Argentaria
BBVA
$147B
| $0 | ﹤0.01% |
+113
| New | +$356 |
|
780
Bath & Body Works
BBWI
$4.13B
| – | – |
-45,540
| Closed | -$652K |
|
781
Bread Financial
BFH
$4.29B
| – | – |
-13,431
| Closed | -$1.18M |
|
782
Chubb
CB
$139B
| – | – |
-21
| Closed | -$2K |
|
783
Codexis
CDXS
$141M
| – | – |
-89,854
| Closed | -$1.4M |
|
784
Check Point Software Technologies
CHKP
$13.6B
| – | – |
-5
| Closed | -$1K |
|
785
Cooper Companies
COO
$13.7B
| – | – |
-3,664
| Closed | -$288K |
|
786
Capri Holdings
CPRI
$1.82B
| – | – |
-216,748
| Closed | -$8.08M |
|
787
CytomX Therapeutics
CTMX
$708M
| – | – |
-741,191
| Closed | -$6.02M |
|
788
California Water Service
CWT
$3.04B
| – | – |
-39,907
| Closed | -$2.01M |
|
789
Delta Air Lines
DAL
$57B
| – | – |
-211,686
| Closed | -$12.1M |
|
790
Diageo
DEO
$47.3B
| – | – |
-6,369
| Closed | -$1.05M |
|
791
DXC Technology
DXC
$1.68B
| – | – |
-16,151
| Closed | -$593K |
|
792
Enanta Pharmaceuticals
ENTA
$370M
| – | – |
-110,139
| Closed | -$6.65M |
|
793
Eagle Materials
EXP
$6.69B
| – | – |
-164,566
| Closed | -$14.6M |
|
794
Fair Isaac
FICO
$29.7B
| – | – |
-6,786
| Closed | -$2.48M |
|
795
Flowserve
FLS
$9.29B
| – | – |
-23,542
| Closed | -$1.15M |
|
796
Fomento Económico Mexicano
FMX
$45B
| – | – |
-4,345
| Closed | -$401K |
|
797
Globe Life
GL
$13.5B
| – | – |
-5,889
| Closed | -$606K |
|
798
GeoPark
GPRK
$615M
| – | – |
-467,000
| Closed | -$10.1M |
|
799
Hasbro
HAS
$12.8B
| – | – |
-28,437
| Closed | -$2.94M |
|
|
HBI
800
DELISTED
Hanesbrands
HBI
| – | – |
-32,640
| Closed | -$474K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2020 Portfolio in Review
As of Q2 2020, Candriam SCA held 903 positions worth $9.47B, up 5% from $9.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $1.13B of net new capital in Q2 2020, opening 107 new positions and adding to 255 existing holdings. Its largest new stake was JD.com: 744,410 shares worth $44.8M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $103M trimmed.
- Candriam SCA's largest Q2 2020 buy was JD.com: 744,410 shares worth $44.8M.
- Candriam SCA added most to Blueprint Medicines in Q2 2020, an estimated $51.9M increase.
- Candriam SCA's biggest Q2 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $103M.
- Candriam SCA fully exited Salesforce in Q2 2020, selling an estimated $62.5M.
- Candriam SCA's ten largest holdings make up 22% of its $9.47B portfolio in Q2 2020.
- Candriam SCA opened 107 new positions and closed 103 in Q2 2020.
- Candriam SCA's portfolio value rose 5% quarter-over-quarter to $9.47B.
Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.